Bob Gilkes

EBO CEO Gege Gatt revealed that former Fortune 500 Executive Bob Gilkes has joined the company as its new Chief Commercial Officer (CCO).

Mr Gilkes “has been part of executive teams in both Fortune 500 public and start-up-venture backed private sector businesses, and has spent several years working across sales strategy, product growth, and partnerships,” EBO said.

Mr Gatt went on to note that he is “thrilled to see [Mr Gilkes] joining EBO during this exciting stage of growth and at a time when EBO is in an excellent market position, with a growing client base and a strong, smart team behind it.”

Mr Gilkes has spent the last 25 years building technology companies, 15 of which have been dedicated to building health technology companies.

The shift in focus took place 17 years ago, when Mr Gilkes’s own daughter was diagnosed with cerebral palsy. Through first-hand experience, Mr Gilkes understood that he could make a difference through his work.

“I work to support digital health innovators – because outcomes really do matter to patients and, sometimes overlooked, to their families,” he said.

Speaking to MaltaCEOs.mt earlier this month, Mr Gatt revealed that EBO is on track to “double in size” both in terms of headcount and revenues in the coming year.

Featured Image:

Bob Gilkes / LinkedIn

Related

Charles Xuereb / Trident Estates Annual Report

Firms not offering flexibility find it difficult to recruit and retain employees, says Trident Estates CEO

30 May 2024
by Fabrizio Tabone

Charles Xuereb notes that the office environment has an impact on corporate culture and lifestyles tenants want to promote.

‘Technology is changing at a rapid pace, so staying at the forefront means we need to adapt’ – BMIT CEO

30 May 2024
by Helena Grech

As the leading local technology company shares its financial results for 2023, CEO Christian Sammut attests that forward-looking plans for ...

Medserv and Regis ‘have forged a powerful alliance,’ says CEO

30 May 2024
by Robert Fenech

The company is celebrating 50 years from the founding of Medserv

‘Past year was predominantly marked by growing competitive pressures,’ says Farsons CEO

30 May 2024
by Fabrizio Tabone

During the financial year ended 31st January 2024, Farsons Group’s pre-tax profit rose by 4.9% to €16.1 million.

Close Bitnami banner
Bitnami